Banaras Hindu University

About: Banaras Hindu University is a education organization based out in Varanasi, Uttar Pradesh, India. It is known for research contribution in the topics: Population & Catalysis. The organization has 11858 authors who have published 23917 publications receiving 464677 citations. The organization is also known as: Kashi Hindu Vishvavidyalay & Benares Hindu University.

Spectra and ratios of identified particles in Au+Au and d+Au collisions at √sNN=200 GeV

Abstract: The transverse momentum (p(T)) spectra and ratios of identified charged hadrons (pi(+/-), K-+/-, p, (p) over bar) produced in root s(NN) = 200 GeV Au + Au and d + Au collisions are reported in five different centrality classes for each collision species. The measurements of pions and protons are reported up to p(T) = 6 GeV/c (5 GeV/c), and the measurements of kaons are reported up to p(T) = 4 GeV/c (3.5 GeV/c) in Au + Au (d + Au) collisions. In the intermediate p(T) region, between 2 and 5 GeV/c, a significant enhancement of baryon-to-meson ratios compared to those measured in p + p collisions is observed. This enhancement is present in both Au + Au and d + Au collisions and increases as the collisions become more central. We compare a class of peripheral Au + Au collisions with a class of central d + Au collisions which have a comparable number of participating nucleons and binary nucleon-nucleon collisions. The p(T)-dependent particle ratios for these classes display a remarkable similarity, which is then discussed.

Controlled drug release characteristics and enhanced antibacterial effect of graphene nanosheets containing gentamicin sulfate

Abstract: A novel methanol derived graphene (MDG) and gentamicin sulfate nanohybrid was prepared, and the loading and release behaviour of gentamicin on MDG is investigated. An efficient drug loading of 2.57 mg mg−1 was obtained at pH 7. By applying release kinetic models, the mechanism of release of the drug from the MDG matrix was found to be following the Korsmeyer–Peppas model. However, the diffusional release exponent (n) value lies below 0.5 demonstrating that the mechanism controlling the drug release is the Fickian diffusion.

Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases

Abstract: Increasing evidence from diverse sources during the past several years has indicated that long-term, low level, chronic inflammation mediates several chronic diseases including cancer, arthritis, obesity, diabetes, cardiovascular diseases, and neurological diseases. The inflammatory molecules and transcription factors, adhesion molecules, AP-1, chemokines, C-reactive protein (CRP), cyclooxygenase (COX)-2, interleukins (ILs), 5-lipooxygenase (5-LOX), matrix metalloproteinases (MMPs), nuclear factor (NF)-kB, signal transducer and activator of transcription 3 (STAT3), tumor necrosis factor (TNF), and vascular endothelial growth factor (VEGF) are molecular links between inflammation and chronic diseases. Thus, suppression of inflammatory molecules could be potential strategy for the prevention and therapy of chronic diseases. The currently available drugs against chronic diseases are highly expensive, minimally effective and produce several side effects when taken for long period of time. The focus of this review is to discuss the potential of nutraceuticals derived from "Mother Nature" such as apigenin, catechins, curcumin, ellagic acid, emodin, epigallocatechin gallate, escin, fisetin, flavopiridol, genistein, isoliquiritigenin, kaempferol, mangostin, morin, myricetin, naringenin, resveratrol, silymarin, vitexin, and xanthohumol in suppression of these inflammatory pathways. Thus, these nutraceuticals offer potential in preventing or delaying the onset of chronic diseases. We provide evidence for the potential of these nutraceuticals from pre-clinical and clinical studies.

J/ψ Production versus transverse momentum and rapidity in p+p collisions at s=200GeV

Abstract: J/psi production in p+p collisions at root s=200 GeV has been measured by the PHENIX experiment at the BNL Relativistic Heavy Ion Collider over a rapidity range of -2.2 < y < 2.2 and a transverse momentum range of 0 < p(T)< 9 GeV/c. The size of the present data set allows a detailed measurement of both the p(T) and the rapidity distributions and is sufficient to constrain production models. The total cross section times the branching ratio is B-ll sigma(J/psi)(pp)=178 +/- 3(stat)+/- 53(sys)+/- 18(norm) nb.